CIPLA

Industry : Pharmaceutical
Founder: Khwaja Abdul Hamied
Founding year : 1935
Key People : Y. K. Hamied (Chairman), Umang Vohra (CEO)
Headquarter : Mumbai, Maharashtra, India
 Founded1935
•Devices
•Cardiovascular
Key PeopleY. K. Hamied (Chairman), Umang Vohra (CEO)
•Children'sMaharashtra,
HeadquarterMumbai, Health India
•Dermatology and Cosmetology
•Diabetes
•HIV/AIDS
•Hepatitis
•Oncology
•Infectious Diseases & Critical Care
•Malaria
•Neurosciences
•Ophthalmology
•Osteoporosis
•Respiratory
•Urology

Subsidiaries
Cipla Limited has more than 50 subsidiaries, a few of which are mentioned below:
•Medpro Pharmaceutica Proprietary Limited
•Medpro-On-Line Proprietary Limited
•Saba Investment Limited
•Sitec Labs Private Limited
•Smith and Couzin Proprietary Limited
•Xeragen Laboratories Proprietary Limited
•Four M Propack Private Limited
•Galilee Marketing Proprietary Limited
•Gardian Cipla Proprietary Limited
•Goldencross Pharma Private Limited
•Inyanga Trading 386 Proprietary Limited
•Jay Precision Pharmaceuticals Private Limited
•Mabpharm Private Limited
•Medica Pharmaceutical Industries Company Limited
•Medispray Laboratories Private Limited
•Mirren
•Avenue Therapeutics Inc
Mergers & Acquisitions
•Avenue: focussed on the development and commercialisation of an intravenous version of Tramadol, a painkiller, US-based Avenue Therapeutics Inc was acquired by Cipla in
November 2018 for about $215 million.
•Mirren: Mirren, a South African over-the-counter (OTC) pharmaceutical manufacturer and distributor, was acquired by Cipla to enhance Cipla's current OTC portfolio.
•Medpro South Africa Ltd: Cipla Medpro South Africa Ltd, South Africa based Cipla’s distribution partner was acquired by the company in 2013 for around $512 million.
•Jay Precision Pharmaceuticals Pvt. Ltd.: Mumbai-based Jay Precision Pharmaceuticals Pvt. Ltd. (Jay Precision) was acquired by Cipla Limited for ₹96 crore ($15.4 million) in
February 2015.
•Mabpharm: 75% stake in Mabpharm Pvt. Ltd. was acquired by Cipla in 2014, making it a fully owned subsidiary of its unit Meditab Specialities Pvt. Ltd.

Key People
•R. Ananthanarayanan: Global Chief Operating Officer (GCOO) of Cipla
•Raju Mistry: President and Global Chief People Officer (GCPO) of Cipla,
•Umang Vohra: the current Global CEO and Managing Director of Cipla Limited

•Corporate Social Responsibility

The CSR activities of Cipla Limited are carried out by Cipla Foundation, its CSR arm which envisions an equitable world built on the foundation of ‘Caring for Life’. The Foundation
partners and collaborates with numerous NGOs with focus on the following domains:
•Health
•Palliative care for terminally ill patients
•Creating awareness on health
•Improving sanitation
•Rendering accessible medical assistance to unprivileged communities
•Supporting Cancer / HIV / Thalassemia patients
•Mobile Medical Units
•Education
•Setting-up / Developing infrastructure for schools
•Arranging training and awareness programmes for adolescents.
•Promoting e-learning
•Enhancing reading culture
•Awarding scholarships for meritorious/needy students
•Providing vocational skills
•Address Social Inequalities
•Supporting old age homes
•Supporting orphans and differently abled
•Environment
•Promoting environmental sustainability
•Promoting the conservation of natural resources
•Promoting of Renewable Energy Resources
•Rural development projects
•Enhancing livelihood
•Undertaking Sustainable Rural Development Projects
•Others
•Undertaking disaster management
•Supporting NGOs & trusts for conducting various programmes/activities
Cipla Palliative Care:
In 1997, Cipla Limited founded the Palliative Care and Training Centre with the motive to support patients and families beyond medicines and treatment in their most difficult of
times. Established in Warje, Pune, the centre has reached out to more than 15,000 patients since the year of establishment, rendering free-of-cost care.

Competitions:
INNOVENTIA, a Cipla Initiative, envisions to be the world’s biggest innovation challenge in healthcare.

Interns at Cipla :
Dipak Shenvi
Ram Dixit